Age-related macular degeneration is a major course of vision problems but recent years have seen the arrival of treatments that might not only slow vision loss, but reverse it. Sharon Solomon from the Wilmer Eye Institute at Johns Hopkins School of Medicine located in Baltimore USA describes the findings from the August 2014 update of the Cochrane Review examining the effects of a class of drugs that might help, the anti-vascular endothelial growth factors.